Investigating the Common Genetic Factors Linking Menopause Onset and Osteoarthritis
-
By
-
Bingru Luo
-
Lili Huang
-
Jing Zhou
-
Panpan Long
-
July 1, 2026
Clinical Scorecard: Investigating the Common Genetic Factors Linking Menopause Onset and Osteoarthritis
At a Glance
| Category | Detail |
|---|
| Condition | Osteoarthritis (OA) |
| Key Mechanisms | Genetic factors, hormonal fluctuations, particularly estrogen levels, influence the development and progression of OA. |
| Target Population | Postmenopausal women and older adults. |
| Care Setting | Research and genetic epidemiology. |
Key Highlights
- OA prevalence has increased significantly from 1990 to 2020.
- Estrogen plays a protective role in joint health, with its decline post-menopause increasing OA risk.
- Genome-wide association studies (GWAS) have identified genetic loci linked to both OA and menopause onset.
- The genetic correlation between OA and menopause is an emerging area of research.
- Understanding genetic factors may lead to new preventive and therapeutic strategies.
Guideline-Based Recommendations
Diagnosis
- Radiographic evidence of OA is present in about 50% of individuals over 60 years of age.
Management
- Focus on hormonal regulation and genetic insights for potential therapeutic approaches.
Monitoring & Follow-up
- Monitor joint health and symptoms in postmenopausal women due to increased OA risk.
Risks
- Increased risk of OA associated with aging and hormonal changes in women.
Patient & Prescribing Data
Individuals diagnosed with osteoarthritis, particularly postmenopausal women.
Potential for targeting genetic factors and hormonal therapies in management.
Clinical Best Practices
- Utilize GWAS data to inform treatment strategies for OA.
- Consider hormonal levels in the assessment and management of OA in women.
Related Resources & Content
